All Stories

It's curtain closed for Spotlight: Gene editing biotech shutters

CRISPR-based Spotlight Therapeutics has shut down, former CEO Mary Haak-Frendscho, Ph.D., confirmed with Fierce Biotech.

Feb 20, 2025 - 13:01
 0
It's curtain closed for Spotlight: Gene editing biotech shutters
CRISPR-based Spotlight Therapeutics has shut down, former CEO Mary Haak-Frendscho, Ph.D., confirmed with Fierce Biotech.
Read More

Tags:

Previous Article

eSOL and Intron Technology enter business partnership for next-generation SDVs i...

Next Article

SolarEdge 2024 financials show ongoing challenges in inverter market

Related Posts

Merck pens $300M-per-product collab with Epitopea to locate 'hidden' tumor antigens

Merck pens $300M-per-product collab with Epitopea to lo...

Feb 19, 2025  0

Harbour offshoot pens $395M biobucks deal for preclinical rival to Neurocrine’s Crenessity

Harbour offshoot pens $395M biobucks deal for preclinic...

Feb 26, 2025  0

Solid Bio's stock soars as early DMD gene therapy data beat expectations

Solid Bio's stock soars as early DMD gene therapy data ...

Feb 18, 2025  0